Xinchun Xu

821 total citations
18 papers, 663 citations indexed

About

Xinchun Xu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xinchun Xu has authored 18 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Xinchun Xu's work include Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Xinchun Xu is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Xinchun Xu collaborates with scholars based in China and United States. Xinchun Xu's co-authors include Jianxin Wang, Jianming Liang, Jing Qin, Ruixiang Li, Yan Yuan, Liang Pang, Ying Zhu, Hongwei Ren, Yuwei He and Meng Zhang and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release and British Journal Of Nutrition.

In The Last Decade

Xinchun Xu

17 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinchun Xu China	11	419	203	131	78	71	18	663
Tiantian Tan China	12	268 0.6×	197 1.0×	173 1.3×	52 0.7×	63 0.9×	18	550
Ziwei Liao China	13	314 0.7×	240 1.2×	185 1.4×	117 1.5×	92 1.3×	25	635
Timo Schomann Netherlands	17	306 0.7×	131 0.6×	204 1.6×	98 1.3×	154 2.2×	35	722
Jingxiao Chen China	14	404 1.0×	108 0.5×	89 0.7×	53 0.7×	42 0.6×	33	666
Caixia He China	12	433 1.0×	82 0.4×	61 0.5×	124 1.6×	114 1.6×	21	812
Caifeng Deng China	12	342 0.8×	201 1.0×	268 2.0×	36 0.5×	219 3.1×	16	808
Bin Feng China	16	413 1.0×	81 0.4×	75 0.6×	185 2.4×	30 0.4×	47	779
Qing Shi China	12	291 0.7×	127 0.6×	102 0.8×	115 1.5×	75 1.1×	39	602
Qingsi Wu China	13	192 0.5×	110 0.5×	85 0.6×	49 0.6×	192 2.7×	18	602

Countries citing papers authored by Xinchun Xu

Since Specialization

Citations

This map shows the geographic impact of Xinchun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinchun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinchun Xu more than expected).

Fields of papers citing papers by Xinchun Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinchun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinchun Xu. The network helps show where Xinchun Xu may publish in the future.

Co-authorship network of co-authors of Xinchun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinchun Xu. A scholar is included among the top collaborators of Xinchun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinchun Xu. Xinchun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Zhang, Meng, et al.. (2025). Ginsenoside compound K-based multifunctional liposomes for the treatment of rheumatoid arthritis. Drug Delivery. 32(1). 2464190–2464190. 6 indexed citations

Xu, Xinchun, et al.. (2024). PUFA and intrahepatic cholestasis of pregnancy: a two-sample Mendelian randomisation analysis. British Journal Of Nutrition. 132(8). 1022–1029.

Xu, Xinchun, et al.. (2023). Systemic immune‐inflammation index is associated with ulcerative plaque in patients with acute ischemic stroke: A single center exploratory study. Journal of Clinical Ultrasound. 52(3). 295–304. 3 indexed citations

Xia, Jiaxuan, Chen Chen, Meichen Dong, et al.. (2023). Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance. Journal of Controlled Release. 364. 23–36. 36 indexed citations

Zou, Xian, Tianfei Liu, Ying Li, et al.. (2022). Long-term divergent selection for residual feed intake in Chinese broiler chickens. Poultry Science. 102(3). 102298–102298. 4 indexed citations

Li, Lei, Xiaomei Yang, Mengfan He, et al.. (2022). The expression and clinical significance of STAMBP in breast cancer. Molecular Biology Reports. 50(1). 899–906. 3 indexed citations

Xu, Hui, et al.. (2021). STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway. Neoplasia. 23(6). 607–623. 19 indexed citations

Xu, Xinchun, Hui Xu, Xiaomei Yang, et al.. (2021). PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway. Journal of Cancer. 12(16). 4945–4957. 12 indexed citations

Vendrami, Camila Lopes, Xinchun Xu, Robert J. McCarthy, et al.. (2020). Body mass index as an indicator of the likelihood of ultrasound visualization of the appendix in pregnant women with suspicion of appendicitis. Abdominal Radiology. 45(9). 2637–2646. 1 indexed citations

10.

Xu, Hui, et al.. (2020). Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD). Journal of Cancer. 11(22). 6675–6685. 17 indexed citations

11.

Yang, Xiaomei, Xinchun Xu, Ling Zhang, et al.. (2020). Deubiquitinase PSMD7 regulates cell fate and is associated with disease progression in breast cancer.. PubMed. 12(9). 5433–5448. 15 indexed citations

12.

Ren, Hongwei, Yuwei He, Jianming Liang, et al.. (2019). Role of Liposome Size, Surface Charge, and PEGylation on Rheumatoid Arthritis Targeting Therapy. ACS Applied Materials & Interfaces. 11(22). 20304–20315. 169 indexed citations

13.

Wang, Shusheng, Xinchun Xu, Yun Zuo, et al.. (2018). Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling. Cancer Letters. 443. 13–24. 80 indexed citations

14.

Yuan, Yan, Ruixiang Li, Liang Pang, et al.. (2017). Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB. ACS Applied Materials & Interfaces. 9(7). 5864–5873. 182 indexed citations

15.

Qin, Jing, et al.. (2017). Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer. Drug Delivery. 24(1). 752–764. 65 indexed citations

16.

Zhang, Biao, Xinchun Xu, Jing Su, et al.. (2015). Urinary metabolomic strategy to evaluate Compound Danshen Dripping Pills for myocardial ischaemia in rats. Journal of Pharmaceutical and Biomedical Analysis. 112. 98–105. 26 indexed citations

17.

Li, Jianping, et al.. (2015). [Innovation of characteristic medicinal cupping devices].. PubMed. 35(8). 819–22. 1 indexed citations

18.

Xue, Xin, Ningning Zheng, Xinchun Xu, et al.. (2013). Metabonomic Strategy to the Evaluation of Chinese Medicine Compound Danshen Dripping Pills Interfering Myocardial Ischemia in Rats. Evidence-based Complementary and Alternative Medicine. 2013. 1–10. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact